Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 1457

1.

Defining the structural basis for human alloantibody binding to human leukocyte antigen allele HLA-A*11:01.

Gu Y, Wong YH, Liew CW, Chan CEZ, Murali TM, Yap J, Too CT, Purushotorman K, Hamidinia M, El Sahili A, Goh ATH, Teo RZC, Wood KJ, Hanson BJ, Gascoigne NRJ, Lescar J, Vathsala A, MacAry PA.

Nat Commun. 2019 Feb 21;10(1):893. doi: 10.1038/s41467-019-08790-1.

2.

Association between HLA-A*3201 allele and oxcarbazepine-induced cutaneous adverse reactions in Eastern Han Chinese population.

Xu J, Shi X, Qiu Y, Zhang Y, Chen S, Shi Y, Deng Y.

Seizure. 2019 Feb;65:25-30. doi: 10.1016/j.seizure.2018.12.011. Epub 2018 Dec 18.

PMID:
30599396
3.

HLA-A*02:07 Allele Associates with Clarithromycin-Induced Cutaneous Adverse Drug Reactions in Chinese Patients.

Chen SA, Zhang LR, Yang FP, Yang LL, Yang Y, Chen ZH, Jiang ML, Xiong H, Zhu HZ, Qi Z, Xing QH, Luo XQ.

Basic Clin Pharmacol Toxicol. 2018 Sep;123(3):308-313. doi: 10.1111/bcpt.13011. Epub 2018 Apr 25.

PMID:
29575644
4.

Prognostic value of HLA-A2 status in advanced non-small cell lung cancer patients.

Mezquita L, Charrier M, Faivre L, Dupraz L, Lueza B, Remon J, Planchard D, Bluthgen MV, Facchinetti F, Rahal A, Polo V, Gazzah A, Caramella C, Adam J, Pignon JP, Soria JC, Chaput N, Besse B.

Lung Cancer. 2017 Oct;112:10-15. doi: 10.1016/j.lungcan.2017.07.004. Epub 2017 Jul 29.

PMID:
29191581
5.

HLA-A*31:01 and carbamazepine-induced DRESS syndrom in a sample of North African population.

Ksouda K, Affes H, Mahfoudh N, Chtourou L, Kammoun A, Charfi A, Chaabane H, Medhioub M, Sahnoun Z, Turki H, Tahri N, Hammami S, Zeghal K.

Seizure. 2017 Dec;53:42-46. doi: 10.1016/j.seizure.2017.10.018. Epub 2017 Oct 27.

6.

Human Leukocyte Antigen Class I and II Variants in Yemeni Patients with Chronic Renal Failure.

Nassar MY, Al-Shamahy HA, Al-Samawi AS, Abu Asba NW, El-Nono IH, Masood HA.

Iran J Immunol. 2017 Sep;14(3):240-249. doi: IJIv14i3A7.

7.

α3-Deletion Isoform of HLA-A11 Modulates Cytotoxicity of NK Cells: Correlations with HIV-1 Infection of Cells.

Zhang XH, Lian XD, Dai ZX, Zheng HY, Chen X, Zheng YT.

J Immunol. 2017 Sep 15;199(6):2030-2042. doi: 10.4049/jimmunol.1602183. Epub 2017 Aug 7.

8.

HLA-A*24:02 as a common risk factor for antiepileptic drug-induced cutaneous adverse reactions.

Shi YW, Min FL, Zhou D, Qin B, Wang J, Hu FY, Cheung YK, Zhou JH, Hu XS, Zhou JQ, Zhou LM, Zheng ZZ, Pan J, He N, Liu ZS, Hou YQ, Lim KS, Ou YM, Hui-Ping Khor A, Ng CC, Mao BJ, Liu XR, Li BM, Kuan YY, Yi YH, He XL, Deng XY, Su T, Kwan P, Liao WP.

Neurology. 2017 Jun 6;88(23):2183-2191. doi: 10.1212/WNL.0000000000004008. Epub 2017 May 5.

9.

Multiple therapeutic peptide vaccines for patients with advanced gastric cancer.

Fujiwara Y, Okada K, Omori T, Sugimura K, Miyata H, Ohue M, Kobayashi S, Takahashi H, Nakano H, Mochizuki C, Shimizu K, Yano M, Nakamura Y, Mori M, Doki Y.

Int J Oncol. 2017 May;50(5):1655-1662. doi: 10.3892/ijo.2017.3955. Epub 2017 Apr 6.

PMID:
28393243
10.

HLA-A*31:01 and lamotrigine-induced severe cutaneous adverse drug reactions in a Korean population.

Kim BK, Jung JW, Kim TB, Chang YS, Park HS, Moon J, Lee ST, Jung KH, Jung KY, Chu K, Lee SK, Kang HR, Park HW.

Ann Allergy Asthma Immunol. 2017 May;118(5):629-630. doi: 10.1016/j.anai.2017.02.011. Epub 2017 Mar 25. No abstract available.

PMID:
28351624
11.

Unconventional Peptide Presentation by Major Histocompatibility Complex (MHC) Class I Allele HLA-A*02:01: BREAKING CONFINEMENT.

Remesh SG, Andreatta M, Ying G, Kaever T, Nielsen M, McMurtrey C, Hildebrand W, Peters B, Zajonc DM.

J Biol Chem. 2017 Mar 31;292(13):5262-5270. doi: 10.1074/jbc.M117.776542. Epub 2017 Feb 8.

12.

Immunological evaluation of peptide vaccination for cancer patients with the HLA -A11+ or -A33+ allele.

Sakamoto S, Matsueda S, Takamori S, Toh U, Noguchi M, Yutani S, Yamada A, Shichijo S, Yamada T, Suekane S, Kawano K, Naitou M, Sasada T, Hattori N, Kohno N, Itoh K.

Cancer Sci. 2017 Apr;108(4):598-603. doi: 10.1111/cas.13189. Epub 2017 Apr 21.

13.

Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.

Nicoletti P, Aithal GP, Bjornsson ES, Andrade RJ, Sawle A, Arrese M, Barnhart HX, Bondon-Guitton E, Hayashi PH, Bessone F, Carvajal A, Cascorbi I, Cirulli ET, Chalasani N, Conforti A, Coulthard SA, Daly MJ, Day CP, Dillon JF, Fontana RJ, Grove JI, Hallberg P, Hernández N, Ibáñez L, Kullak-Ublick GA, Laitinen T, Larrey D, Lucena MI, Maitland-van der Zee AH, Martin JH, Molokhia M, Pirmohamed M, Powell EE, Qin S, Serrano J, Stephens C, Stolz A, Wadelius M, Watkins PB, Floratos A, Shen Y, Nelson MR, Urban TJ, Daly AK; International Drug-Induced Liver Injury Consortium, Drug-Induced Liver Injury Network Investigators, and International Serious Adverse Events Consortium.

Gastroenterology. 2017 Apr;152(5):1078-1089. doi: 10.1053/j.gastro.2016.12.016. Epub 2016 Dec 30.

14.

HLA-A*02-B*46 haplotype: an adverse prognostic factor in Han patients with nasopharyngeal carcinoma.

Wang RZ, Zhang DG, Wu R, Hu YH, Peng YC, Chang C, Dong T, Wang XY.

J Huazhong Univ Sci Technolog Med Sci. 2016 Oct;36(5):700-704. doi: 10.1007/s11596-016-1647-y. Epub 2016 Oct 18.

PMID:
27752910
15.

HLA-A*02 alleles are associated with tetanus antitoxin-induced exanthematous drug eruptions in Chinese patients.

Yan S, Chen SA, Zhang W, Yang F, Yang Y, Zhu Q, Zhu H, Sun X, Jiang M, Su Y, Zhang L, Xing Q, Luo X.

Pharmacogenet Genomics. 2016 Dec;26(12):538-546.

PMID:
27749688
16.

Lack of Heterologous Cross-reactivity toward HLA-A*02:01 Restricted Viral Epitopes Is Underpinned by Distinct αβT Cell Receptor Signatures.

Grant EJ, Josephs TM, Valkenburg SA, Wooldridge L, Hellard M, Rossjohn J, Bharadwaj M, Kedzierska K, Gras S.

J Biol Chem. 2016 Nov 18;291(47):24335-24351. Epub 2016 Sep 19.

17.

Human leucocyte antigen Class I and II alleles associated with anti-hepatitis C virus-positive patients of North India.

Chowdhry M, Makroo RN, Singh M, Agrawal S, Kumar M, Thakur Y.

Indian J Med Microbiol. 2016 Jul-Sep;34(3):299-302. doi: 10.4103/0255-0857.188317.

18.

Association between HLA-A1 and -A2 types and Epstein-Barr virus status of post-transplant lymphoproliferative disorder.

Kinch A, Sundström C, Tufveson G, Glimelius I.

Leuk Lymphoma. 2016 Oct;57(10):2351-8. doi: 10.3109/10428194.2016.1173209. Epub 2016 Apr 22.

PMID:
27104753
19.

Genomic full-length sequence of a novel HLA-A*11:01:01:02 allele was identified in a Chinese bone marrow donor.

He J, He Y, Wang W, Han Z, He J, Chen N, Dong L, Tao S, Zhang W, Zhu F.

Int J Immunogenet. 2016 Jun;43(3):184-6. doi: 10.1111/iji.12261. Epub 2016 Apr 15.

PMID:
27079157
20.

Identification of HLA-A*11:01-restricted Mycobacterium tuberculosis CD8(+) T cell epitopes.

Liu SD, Su J, Zhang SM, Dong HP, Wang H, Luo W, Wen Q, He JC, Yang XF, Ma L.

J Cell Mol Med. 2016 Sep;20(9):1718-28. doi: 10.1111/jcmm.12867. Epub 2016 Apr 12.

Supplemental Content

Support Center